Use of BMPs and bisphosphonates to improve bone fracture healing

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 7, 2012, Pages 2647-2653

  Yu, Nicole Y C ^a,c   Schindeler, Aaron ^a,b   Tägil, Magnus ^d   Ruys, Andrew J ^c   Little, David G ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b University of Sydney   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anabolism; Bisphosphonate; Bone morphogenetic protein (BMP); Bone tissue engineering; Catabolism; Review

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; CLODRONIC ACID; EOSIN; HEMATOXYLIN; IBANDRONIC ACID; OSTEOGENIC PROTEIN 1; PAMIDRONIC ACID; RISEDRONIC ACID; SODIUM CHLORIDE; ZOLEDRONIC ACID;

ARTICLE; BONE CONDUCTION; BONE DENSITY; BONE GRAFT; BONE MINERAL; BONE REMODELING; BONE STRENGTH; BONE TRANSPLANTATION; CALLUS; DISTRACTION OSTEOGENESIS; DRUG EFFICACY; DRUG MEGADOSE; EXTERNAL FIXATOR; FEMUR HEAD; FOLLOW UP; GANGRENE; HETEROTOPIC OSSIFICATION; HISTOLOGY; HUMAN; KNEE OSTEOARTHRITIS; NONHUMAN; OBSERVATIONAL STUDY; OSSIFICATION; OSTEOCLAST ACTIVITY; OSTEOLYSIS; OSTEOPOROSIS; OSTEOTOMY; PIGLET; POSTOPERATIVE PERIOD; PSEUDARTHROSIS; RABBIT MODEL; TIBIA OSTEOTOMY; TISSUE GROWTH; TREATMENT DURATION; FRACTURE HEALING; PHYSIOLOGY; REVIEW;

BONE MORPHOGENETIC PROTEINS; DIPHOSPHONATES; FRACTURE HEALING; HUMANS;

EID: 84867291582     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e572     Document Type: Article

References (32)

1. Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn MW, Julian MW, Gillespie MT, Martin TJ, Suda T, Takahashi N: Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kB Ligand. Endocrinology 142: 3656-3662 (2001) (Pubitemid 32681777)
2. Kaneko H, Arakawa T, Mano H, Kaneda T, Ogasawara A, Nakagawa M, Toyama Y, Yabe Y, Kumegawa M, Hakeda Y: Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone 27: 479 (2000)
3. Paul S, Lee J, Yeh L: A comparative study on BMP-induced osteoclastogenesis and osteoblastogenesis in primary cultures of adult rat bone marrow cells. Growth Factors 27 (2009)
4. Katagiri T, Takahashi N: Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Diseases 8: 147- 159 (2002) (Pubitemid 34535063)
5. Pradhan B, Bae H, Dawson E, Patel V, Delamarter R: Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2. Spine (Phila Pa 1976) 31: E377-384 (2006)
6. Kärrholm J, Hourigan P, Timperley J, Razaznejad R: Mixing bone graft with OP-1 does not improve cup or stem fixation in revision surgery of the hip: 5-year follow-up of 10 acetabular and 11 femoral study cases and 40 control cases. Acta Orthop 77: 39048 (2006)
7. Little DG, Ramachandran M, Schindeler A: The anabolic and catabolic responses in bone repair. J Bone Joint Surg Br 89-B: 425-433. (2007) (Pubitemid 46851119)
8. Little D, Cornell M, Hile M, Briody J, Cowell C, Bilston L: Effect of pamidronate on distraction osteogenesis and fixatorrelated osteoporosis. Injury 32: SD14-20 (2001)
9. Little D, McDonald M, Bransford R, Godfrey C, Amanat N. Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model. J Bone Miner Res 20: 2044-2052 (2005) (Pubitemid 41532790)
10. Little D, Smith N, Williams P, Briody J, Bilston L, Smith E, Gardiner E, Cowell C: Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis. J Bone Miner Res 18: 300-307 (2003)
11. Amanat N, Brown R, Bilston L, Little D: A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair. J Orthop Res 23: 1029-1034. (2005) (Pubitemid 41245425)
12. Amanat N, McDonald M, Godfrey C, Bilston L, Little D: Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair. J Bone Miner Res 22 (6):867-876 (2007) (Pubitemid 351339747)
13. Schindeler A, Little D: Bisphosphonate action: revelations and deceptions from in vitro studies. J Pharm Sci 96: 1872-1878 (2007) (Pubitemid 47280088)
14. Rogers M: New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des 9: 2643- 2658 (2003) (Pubitemid 37456015)
15. Russell R, Xia Z, Dunford J, Oppermann U, Kwaasi A, Hulley P, Kavanagh K, Triffitt J, Lundy M, Phipps R: Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci 1117: 209-257 (2007) (Pubitemid 350191297)
16. Schindeler A, McDonald M, Bokko P, Little D: Bone remodelling during fracture repair: The cellular picture. Semin Cell Dev Biol 19: 459-466 (2008)
17. McDonald M, Dulai S, Godfrey C, Sztynda T, Little D: Osteoclasts are functionally redundant in initial endochondral fracture union but not callus remodelling: Insights into optimal bisphosphonate dosing. J Bone Miner Res 21: S398 (2006)
18. Harding A, Toksvig-Larsen S, Tägil M, W-Dahl A: A single dose zoledronic acid enhances pin fixation in high tibial osteotomy using the hemicallotasis technique. A double-blind placebo controlled randomized study in 46 patients. Bone 46: 649-654 (2010)
19. Harding AK, Aspenberg P, Kataoka M, Bylski D, Tägil M: Manipulating the anabolic and catabolic response in bone graft remodeling: Synergism by a combination of local BMP-7 and a single systemic dose of zoledronate. J Orthop Res 26: n/1245-1249 (2008)
20. Gong L, Hoshi K, Ejiri S, Nakajima T, Shingaki S, Ozawa H: Bisphosphonate incadronate inhibits maturation of ectopic bone induced by recombinant human bone morphogenetic protein 2. JBMM 21: 5-11 (2003) (Pubitemid 41199632)
21. Schindeler A, Little D. Recent insights into bone development, homeostasis, and repair in type 1 neurofibromatosis (NF1): Bone 42: 616-622 (2008)
22. Schindeler A, Ramachandran M, Godfrey C, Morse A, McDonald M, Mikulec K, Little DG: Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice J Orthop Res 26: 65-74 (2008)
23. Birke O, Schindeler A, Ramachandran M, Cowell C, Munns C, Bellemore M, Little D: Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia J Child Orthop 4: 507-517 (2010)
24. Jeppsson C, Åstrand J, Tägil M, Aspenberg P: A combination of bisphosphonate and BMP additives in impacted bone allografts Acta Orthopaedica Scandinavica 74: 483-489 (2003) (Pubitemid 37108471)
25. Belfrage O, Flivik G, Sundberg M, Kesteris U, Tägil M: Local treatment of cancellous bone grafts with BMP-7 and zoledronate increases both bone formation rate and bone density. A bone chamber study in rats. Acta Orthopedica 82 (2):228-233 (2011)
26. Chen W-J, Jingushi S, Hirata G, Matsumoto Y, Iwamoto Y: Intramuscular bone inducation by the simultaneous administration of recombinant human bone morphogenetic protein 2 and bisphosphonate for autobone graft. Tissue Eng 10: 1652-1661. (2004) (Pubitemid 40054207)
27. Chen W-J, Jingushi S, Jingushi K, Iwamoto Y: In vivo banking for vascularized autograft bone by intramuscular inoculation of recombinant human bone morphogenetic protein-2 and β-tricalcium phosphate. J Orthop Sci 11: 283- 288 (2006) (Pubitemid 43806836)
28. Vandermeer J, Kamiya N, Aya-ay J, Garces A, Browne R, Kim H: Local administration of ibandronate and bone morphogenetic protein-2 stimulates bone formation and decreases femoral head deformity following ischemic osteonecrosis of the immature femoral head. J Bone Joint Surg Am 93 (10):905-13 (2011)
29. Choi J-Y, Kim H-J, Lee Y-C, Cho B-O, Seong H-S, Cho M, Kim S-G: Inhibition of bone healing by pamidronate in calvarial bony defects. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103: 321-328 (2007)
30. Jakobsen T, Baas J, Bechtold JE, Elmengaard B, Soballe K: Soaking morselized allograft in bisphosphonate can impair implant fixation. Clin Orthop Relat Res 463: 195-201 (2007) (Pubitemid 47585271)
31. Baas J, Elmengaard B, Jensen TB, Jakobsen T, Andersen NT, Soballe K: The effect of pretreating morselized allograft bone with rhBMP-2 and/or pamidronate on the fixation of porous Ti and HA-coated implants. Biomaterials 29: 2915-2922 (2008)
32. Yu NYC, Schindeler A, Peacock L, Mikulec K, Baldock PA, Ruys AJ, Little DG: In vivo local co-delivery of recombinant human bone morphogenetic protein-7 and pamidronate via poly-D, L-lactic acid. Eur Cell Mater 20: 431-442 (2010)